Over $4 million in funding for
rejuvenation biotech research.
New Organ is an initiative of the
Methuselah Foundation, a public
charity dedicated to advancing
and celebrating regenerative
technologies to reduce unnecessary
suffering and extend healthy life.
Over $4 million in funding for
rejuvenation biotech research.
Critical early-stage funding for
Organovo (NASDAQ: ONVO).
The Mouse Prize, the first large
prize for rejuvenation research.
Funding that enabled Silverstone
to do kidney matching online.
Director, Wake Forest Institute
for Regenerative Medicine
Deputy Dir., McGowan Institute
for Regenerative Medicine
Dir., MIT Lab for Multiscale
Regenerative Technologies
Co-Dir., Tissue Engineering at
Nationwide Children's Hospital
Assoc. Prof., Sanford Consortium
for Regenerative Medicine
CTO & Vice President of
R&D, TeVido Biodevices
Dir. of Hepatology, Medicine
Service, Mass General
Clinical Reader & Head of Surgery
Unit, University College of London
William Wikoff Smith Professor of
Cardiovascular Research, UPenn
Scientific Founder, Organovo,
Co-Founder, Modern Meadow
Asst. Prof., Dept. of Medicine,
Harvard Medical School
Assistant Professor, Mount
Sinai School of Medicine
Director, Cell Therapy Program,
Princess Margaret Hospital
Director, Cancer Stem Cell
Center, McGowan Institute
David H. Koch Institute
Professor, MIT
Physician, Scientist
Max Planck Institute of Psychiatry
Chair, Regenerative Medicine
Bioprocessing, UCL
Professor, Dept. of Pediatrics,
Cincinnati Children’s Hospital
Institute Professor Emeritus,
Georgia Institute of Technology
Professor of Anesthesiology &
Biomedical Engineering, Yale
Instructor in Surgery,
Harvard Medical School
Director, Center for Regenerative
Medicine at the Mayo Clinic
Assistant Professor in Surgery,
Harvard Medical School
Surgeon in Chief, Mass General
Hospital for Children
NASA Ames Space Portal
Microgravity Lead
Academy Professor & Director, Center for Molecular Science, U.S Military Academy
Exec Dir., Regenerative
Medicine Foundation
Chairman and CEO,
Organovo
Founding Dir., Biolatris, Co-
Founder, univerCELLmarket
Exec Dir., Pittsburgh Tissue
Engineering Initiative
Founder & Exec Dir.,
Genetics Policy Institute
Director, McGowan Institute
for Regenerative Medicine
The Institute of Competition Sciences
oversees New Organ’s strategy,
design, and operations. ICS has
worked previously with NASA, SETI,
Goodwill, Lemelson Foundation, et al.
ICS CEO
Josh has extensive experience managing charities
and challenge prizes. Since beginning his career
at X PRIZE, he has gone on to co-found ICS to
help catalyze the prize competition industry.
New Organ Social Media Manager
With 10 years of experience in social media, Florina
manages New Organ’s presence on Facebook and
Twitter, sharing the latest in regenerative medicine.
New Organ Founder and Methuselah CEO
A forward-looking entrepreneur and father, Dave
co-founded Methuselah in 2003 with Dr. Aubrey de
Grey. He continues to work tirelessly to advance
breakthroughs that will extend healthy life.
Chief Science Advisor
Kevin is Executive Director of the Mprize, founder
of AgeNet and co-founder of SENS Research
Foundation, and is currently working on the role
of cellular senescence in degenerative disease at
the Buck Institute for Research on Aging.
Personal information supplied to New Organ is used solely for internal
purposes and will never be supplied to any third party. Individuals
visiting neworgan.org may elect
to receive occasional email communications including updates concerning our progress, opportunities to
participate in projects, and general communications related to our activities. Receiving
such emails is purely voluntary and may be unsubscribed
from at any time by contacting us at info@neworgan.org or by clicking
"unsubscribe" in any unwanted email.